Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kinerase Pro+Therapy is a topical skincare regimen developed for the treatment of visible signs of skin aging, including fine lines, wrinkles, and hyperpigmentation. The primary active ingredient is kinetin (N6-furfuryladenine), a plant-derived cytokinin that acts as a potent antioxidant. Kinetin is believed to protect cellular DNA and proteins from oxidative damage and may delay cellular senescence by improving the skin's natural barrier function and moisture retention. The Pro+Therapy line is typically administered as a multi-product regimen consisting of a day repair cream, a serum, and a night repair treatment, often evaluated in clinical settings for its efficacy compared to standard moisturizers or single-ingredient products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kinerase Pro+Therapy.